The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

BACKGROUND: In many tumour types serumlactate dehydrogenase (LDH) levels proved to represent an indirect marker of tumour hypoxia, neo-angiogenesis and worse prognosis. As we previously reported LDH is an important predictive factor in hepatocellular carcinoma (HCC) patients undergoing transarterial...

Descripción completa

Detalles Bibliográficos
Autores principales: Faloppi, Luca, Scartozzi, Mario, Bianconi, Maristella, Svegliati Baroni, Gianluca, Toniutto, Pierluigi, Giampieri, Riccardo, Del Prete, Michela, De Minicis, Samuele, Bitetto, Davide, Loretelli, Cristian, D’Anzeo, Marco, Benedetti, Antonio, Cascinu, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930857/
https://www.ncbi.nlm.nih.gov/pubmed/24552144
http://dx.doi.org/10.1186/1471-2407-14-110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930857/
https://www.ncbi.nlm.nih.gov/pubmed/24552144
http://dx.doi.org/10.1186/1471-2407-14-110

Ejemplares similares